RSS

Medivir

The AMR Centre and Swedish company Medivir have signed an exclusive licensing agreement aimed at tackling NDM-1 and other metallo-β-lactamases, which make bacteria resistant to widely-used antibiotics. more

News

Team work: Beatica has entered into an agreement with Medivir to identify novel hits against a disease-relevant protease more

News